Home – Maiwald

我们在以上方面助您一臂之力

个性化的咨询和具有前瞻性的行动是奠定我们成功的基石。您尽可以信任我们一流的律师和专利律师团队，他们在知识产权保护领域的各个方面都富有经验。

关于业务领域的更多内容

保护

我们帮助您对您的知识产权进行保护与辩护，并在世界范围内专利组合的协调方面有着特别丰富的专业知识。

了解更多信息

诉讼

在专利侵权和专利有效性诉讼程序中，我们会竭诚为您提供支持。

了解更多信息

交易

我们从专利法的角度为您在合同谈判中出谋划策，并在企业并购交易过程中予以陪同。

了解更多信息

咨询

我们就专利申请策略为您提供咨询，评估自由实施（FTO）的相关问题以及专利权的有效性。

了解更多信息

News

14 Jul 2025

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization ...

14 Jul 2025

Eight Opponents Succeed in Revocation of Salix’s Rifaximin Patent at the EPO

In a significant development, the European Patent Office (EPO) has revoked Salix Pharmaceuticals’ European patent for the antibiotic rifaximin. In decision T 0162/22, the ...

9 Jul 2025

EP 3 996 688 Maintained as Granted: Maiwald Successfully Defends Formulation Patent for Tepotinib

We are happy to report that we successfully defended Merck’s formulation patent EP 3 996 688 for c-Met inhibitor Tepotinib (TEPMETKO®) in opposition proceedings at the hea...

我们助您打造未来。

我们在以上方面助您一臂之力

保护

诉讼

交易

咨询

News

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Eight Opponents Succeed in Revocation of Salix’s Rifaximin Patent at the EPO

EP 3 996 688 Maintained as Granted: Maiwald Successfully Defends Formulation Patent for Tepotinib